Therapeutic area
Gastroenterology & Hepatology
Inflammatory bowel disease, liver diseases, metabolic dysfunction-associated steatohepatitis, and digestive system disorders.
Core & active disease programs
Provisional & emerging programs (14)Early clinical pipeline & single-asset indications
Metabolic Dysfunction-Associated Steatohepatitis
Cholestatic Liver Disease
Irritable Bowel Syndrome
Alagille Syndrome
Celiac Disease
Crohn's Disease
Eosinophilic Esophagitis
Gastroparesis
HIV-Associated Diarrhea
Liver Failure
Primary Sclerosing Cholangitis
Short Bowel Syndrome
Toxicology / Acetaminophen Overdose
Travelers' Diarrhea